The companies reached agreement on the distribution of stem cell and platelet-rich plasma kits and associated tissue-processing equipment to veterinary practices nationwide.

Jeff Baker, vice president of sales at Devens, Mass.-based Patterson, called MediVet “a forward-thinking company that is a leader in the emerging regenerative therapy segment.”

“MediVet’s line of stem cell therapies and equipment is a strong addition to the Patterson Veterinary portfolio of cutting-edge technologies,” Baker said.

The companies have developed an educational platform designed to help veterinarians learn about stem cell therapy.

More than 550 veterinarians in 47 states perform in-clinic stem cell procedures, noted MediVet, which is headquartered in Nicholasville, Ky.

Adult animal stem cell technology uses the body’s regenerative healing power to treat dogs, cats, horses and other animals suffering from arthritis, hip dysplasia, tendon, ligament and cartilage injuries, and other ailments. The stem cell kit allows for same-day harvest and application of repair cells derived from an animal’s fat tissue.

MediVet stem cell technology also is distributed by Henry Schein Animal Health of Dublin, Ohio.

 

Read the original article on the Veterinary Practice News website here.

 

Read the full press release on the Patterson Veterinary Company website here.

 

<<< Return to News

Share This